首页> 外文OA文献 >Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people : a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)
【2h】

Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people : a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)

机译:多层足病干预对老年人跌倒预防的临床效果和成本效益:多中心队列随机对照试验(REducing Falls with ORthoses and a multifaceted podiatry intervention trial)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Falls are a serious cause of morbidity and cost to individuals and society. Evidence suggests that foot problems and inappropriate footwear may increase the risk of falling. Podiatric interventions could help reduce falls; however, there is limited evidence regarding their clinical effectiveness and cost-effectiveness. OBJECTIVES: To determine the clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for preventing falls in community-dwelling older people at risk of falling, relative to usual care. DESIGN: A pragmatic, multicentred, cohort randomised controlled trial with an economic evaluation and qualitative study. SETTING: Nine NHS trusts in the UK and one site in Ireland. PARTICIPANTS: In total, 1010 participants aged ≥ 65 years were randomised (intervention, n = 493; usual care, n = 517) via a secure, remote service. Blinding was not possible. INTERVENTIONS: All participants received a falls prevention leaflet and routine care from their podiatrist and general practitioner. The intervention also consisted of footwear advice, footwear provision if required, foot orthoses and foot- and ankle-strengthening exercises. MAIN OUTCOME MEASURES: The primary outcome was the incidence rate of falls per participant in the 12 months following randomisation. The secondary outcomes included the proportion of fallers and multiple fallers, time to first fall, fear of falling, fracture rate, health-related quality of life (HRQoL) and cost-effectiveness. RESULTS: The primary analysis consisted of 484 (98.2%) intervention and 507 (98.1%) usual-care participants. There was a non-statistically significant reduction in the incidence rate of falls in the intervention group [adjusted incidence rate ratio 0.88, 95% confidence interval (CI) 0.73 to 1.05; p = 0.16]. The proportion of participants experiencing a fall was lower (50% vs. 55%, adjusted odds ratio 0.78, 95% CI 0.60 to 1.00; p = 0.05). No differences were observed in key secondary outcomes. No serious, unexpected and related adverse events were reported. The intervention costs £252.17 more per participant (95% CI -£69.48 to £589.38) than usual care, was marginally more beneficial in terms of HRQoL measured via the EuroQoL-5 Dimensions [mean quality-adjusted life-year (QALY) difference 0.0129, 95% CI -0.0050 to 0.0314 QALYs] and had a 65% probability of being cost-effective at the National Institute for Health and Care Excellence threshold of £30,000 per QALY gained. The intervention was generally acceptable to podiatrists and trial participants. LIMITATIONS: Owing to the difficulty in calculating a sample size for a count outcome, the sample size was based on detecting a difference in the proportion of participants experiencing at least one fall, and not the primary outcome. We are therefore unable to confirm if the trial was sufficiently powered for the primary outcome. The findings are not generalisable to patients who are not receiving podiatry care. CONCLUSIONS: The intervention was safe and potentially effective. Although the primary outcome measure did not reach significance, a lower fall rate was observed in the intervention group. The reduction in the proportion of older adults who experienced a fall was of borderline statistical significance. The economic evaluation suggests that the intervention could be cost-effective. FUTURE WORK: Further research could examine whether or not the intervention could be delivered in group sessions, by physiotherapists, or in high-risk patients. TRIAL REGISTRATION: Current Controlled Trials ISRCTN68240461. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 24. See the NIHR Journals Library website for further project information.
机译:背景:跌倒是造成发病的严重原因,并给个人和社会造成了损失。有证据表明,脚部问题和不适当的鞋类可能会增加跌倒的风险。儿科干预可以帮助减少跌倒;但是,关于其临床有效性和成本效益的证据有限。目的:相对于常规护理,确定多方面的足病干预措施在预防有跌倒危险的社区居民中跌倒方面的临床效果和成本效益。设计:一项实用,多中心,队列的随机对照试验,并进行了经济评估和定性研究。地点:九个NHS信任英国和爱尔兰的一个站点。参与者:总共有1010名年龄≥65岁的参与者通过安全的远程服务被随机分配(干预,n = 493,常规护理,n = 517)。不可能致盲。干预措施:所有参与者都从足病医生和全科医生那里获得了防摔传单和常规护理。干预措施还包括鞋类建议,必要时提供鞋类,矫形足以及加强脚踝的锻炼。主要观察指标:主要观察结果是随机分组后12个月内每个参与者的跌倒发生率。次要结果包括跌倒者和多次跌倒者的比例,第一次跌倒的时间,对跌倒的恐惧,骨折率,健康相关的生活质量(HRQoL)和成本效益。结果:主要分析包括484名(98.2%)干预措施和507名(98.1%)常规护理参与者。干预组跌倒的发生率没有统计学意义的显着降低[调整后的发生率比率为0.88,95%置信区间(CI)为0.73至1.05; p = 0.16]。跌倒的参与者比例较低(50%比55%,调整后的优势比0.78,95%CI为0.60至1.00; p = 0.05)。关键的次要结局未见差异。没有严重,意外和相关不良事件的报道。每名参与者的干预费用比常规护理多252.17英镑(95%CI-69.48英镑至589.38英镑),通过EuroQoL-5维度[平均质量调整生命年(QALY)差异)衡量的HRQoL略有益处0.0129,95%CI -0.0050至0.0314 QALYs),在美国国立卫生研究院卓越门槛(每QALY 30,000英镑)下具有成本效益的概率为65%。足病医生和试验参与者通常可以接受这种干预。局限性:由于难以计算计数结果的样本量,因此样本量是基于检测到经历至少一次跌倒而非主要结果的参与者比例的差异。因此,我们无法确认该试验是否足以支持主要结果。该发现不适用于未接受足病治疗的患者。结论:该干预是安全的并且可能有效。尽管主要结局指标未达到显着水平,但干预组的跌倒率较低。经历跌倒的老年人比例的降低具有统计学意义。经济评估表明,干预措施可能具有成本效益。未来的工作:进一步的研究可以检查是否可以在小组会议上,物理治疗师或高危患者中进行干预。试用注册:电流控制试验ISRCTN68240461。资金:该项目由美国国立卫生研究院(NIHR)卫生技术评估计划资助,将在《卫生技术评估》中全文发表;卷21,第24号。有关更多项目信息,请参见NIHR Journals Library网站。

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号